1. Braam, P. Diarrhea caused by enterohemorrhagic strains. In: Heymann, DLed. Control of Communicable Diseases Manual, 18th edn. Washington, DC: American Public Health Association, 2004, pp. 160–171.
2. Thorpe, CM. Shiga toxin-producing Escherichia coli infection. Clinical Infectious Diseases 2004; 38: 1298–1303.
3. Tarr, PI, Gordon, CA, Chandler, WL. Shiga-toxin-producing Escherichia coli and hemolytic uraemic syndrome. Lancet 2005; 365: 1073–1086.
4. Decludt, B, et al. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. Epidemiology and Infection 2000; 124: 215–220.
5. Espié, E, et al. Surveillance of hemolytic uremic syndrome in children aged less than 15 years in France, 2002 and 2003 [in French]. Bulletin Epidémiologique Hebdomadaire 2004; 42: 203–204 (http://www.invs.sante.fr/beh/2004/42/beh_42_2004.pdf). Accessed 28 July 2008.
6. Bidet, P, et al. Characterization of Escherichia coli O157:H7 isolates causing haemolytic uraemic syndrome in France. Journal of Medical Microbiology 2005; 54: 71–75.
7. Vernozy-Rozand, C, et al. Prevalence of Escherichia coli O157:H7 in industrial minced beef. Letters in Applied Microbiology 2002; 35: 7–11.
8. Tenover, FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233–2239.
9. Espié, E, et al. Escherichia coli O157 outbreak associated with fresh unpasteurized goats' cheese. Epidemiology and Infection 2006; 134: 143–146.
10. Haeghebaert, S, et al. Surveillance of hemolytic uremic syndrome in children aged less than 15 years in France in 2001 [in French]. Bulletin Epidémiologique Hebdomadaire 2003; 20: 89–91 (http://www.invs.sante.fr/beh/2003/20/beh_20_2003.pdf). Accessed 28 July 2008. 11. Espié, E, et al. Risk factors for sporadic cases of hemolytic uremic syndrome in children aged less than 15 years in France: case control study 2000–2001 [in French]. Bulletin Epidémiologique Hebdomadaire 2003; 20: 91–92 (http://www.invs.sante.fr/beh/2003/20/beh_20_2003.pdf). Accessed 28 July 2008.
12. Rangel, JM, et al. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982–2002. Emerging Infectious Diseases 2005; 11: 603–609.
13. Tuttle, J, et al. Lessons from a large outbreak of Escherichia coli O157:H7 infections: insights into the infectious dose and method of widespread contamination of hamburger patties. Epidemiology and Infection 1999; 122: 185–192.
14. Vogt, RL, Dippold, L. Escherichia coli O157:H7 outbreak associated with consumption of ground beef, June–July 2002. Public Health Reports 2005; 120: 174–178.
15. Centers for Disease Control and Prevention. Escherichia coli O157:H7 infections associated with eating a nationally distributed commercial brand of frozen ground beef patties and burgers – Colorado, 1997. Morbidity and Mortality Weekly Report 1997; 46: 777–778.
16. Belongia, EA, et al. An outbreak of Escherichia coli O157:H7 colitis associated with consumption of precooked meat patties. Journal of Infectious Diseases 1991; 164: 338–343.
17. Haeghebaert, S, et al. Minced beef and human salmonellosis: review of the investigation of three outbreaks in France. Eurosurveillance 2001; 6(2): 21–26.
18. Chapman, PA, et al. Cattle as a possible source of verotoxin-producing Escherichia coli O157 infection in man. Epidemiology and Infection 1993; 111: 439–447.
19. Elder, RO, et al. Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing. Proceedings of the National Academy of Sciences USA 2000; 97: 2999–3003.
20. Maki, DG. Don't eat the spinach – controlling foodborne infectious disease. New England Journal of Medicine 2006; 355: 1952–1955.
21. Griffin, PM, Tauxe, RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorragic E. coli and the associated haemolytic uremic syndrome. Epidemiologic Reviews 1991; 13: 60–98.
22. Tarr, PI. Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clinical Infectious Diseases 1995; 20: 1–10.
23. Ochoa, TJ, Cleary, TG. Epidemiology and spectrum of disease of Escherichia coli O157; Current Opinion in Infectious Diseases 2003; 102: 259–263.
24. Bielaszewska, M, et al. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clinical Infectious Diseases. 2006; 43: 1160–1167.